Achiko signs agreement with PT Indonesia Farma Medis to establish a new joint venture, including a contract with PT Mitra Asa Pratama and a memorandum of understanding with PT Pharos Indonesia, completion subject to formal approvalsTest kits will be integrated with Achiko’s Teman Sehat (Health … [Read more...]
2021 Extraordinary Shareholders’ Meeting of Achiko AG: shareholders adopt all proposals
Zurich, 11 February 2021 – Achiko AG (SWX: ACHI, ISIN CH0522213468) (“Achiko” or the “Company”) held an extraordinary shareholders’ meeting today at 10:00 CET in Zurich. Due to the Covid-19 pandemic, this Extraordinary Shareholders’ Meeting was held without physical presence of the shareholders in … [Read more...]
Achiko concludes Phase 1 study of Project Gumnuts for Covid-19 testing
Completion of Phase 1 testing demonstrates 91% sensitivity and 85% specificityFurther optimisation studies are currently being performed and are expected to continue to improve results and match WHO standardsNext steps are completion of regulatory approvals and moving the technology to market as … [Read more...]
Achiko AG invites shareholders to an Extraordinary Shareholders’ Meeting on 11 February 2021
Zurich, 19 January 2021 – Achiko AG (SWX:ACHI, ISIN CH0522213468) has published the notice regarding an Extraordinary Shareholders’ Meeting at 10:00 a.m. (CET) on 11 February 2021 in Zurich.Due to the Covid-19 pandemic, this Extraordinary Shareholders’ Meeting will be held in accordance with … [Read more...]
Achiko strengthens leadership team with
new President and new SVP Commercialisation
Appoints new President, biotechnology research scientist and entrepreneur Dr. Morris S. BerrieAppoints new SVP Commercialisation, business leader in life science Richard LingardNew senior leadership expected to drive production and commercialisation for Gumnuts, Achiko’s test kit for … [Read more...]